BioLife Solutions PE Ratio 2010-2025 | BLFS
Current and historical p/e ratio for BioLife Solutions (BLFS) from 2010 to 2025. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. BioLife Solutions PE ratio as of August 27, 2025 is 2543.00.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
| BioLife Solutions PE Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Net EPS | PE Ratio |
| 2025-08-27 | 25.43 | 0.00 | |
| 2025-06-30 | 21.54 | $-0.12 | 0.00 |
| 2025-03-31 | 22.84 | $-0.29 | 0.00 |
| 2024-12-31 | 25.96 | $-0.50 | 0.00 |
| 2024-09-30 | 25.04 | $-1.06 | 0.00 |
| 2024-06-30 | 21.43 | $-1.69 | 0.00 |
| 2024-03-31 | 18.55 | $-1.42 | 0.00 |
| 2023-12-31 | 16.25 | $-1.52 | 0.00 |
| 2023-09-30 | 13.81 | $-2.37 | 0.00 |
| 2023-06-30 | 22.10 | $-1.93 | 0.00 |
| 2023-03-31 | 21.75 | $-3.41 | 0.00 |
| 2022-12-31 | 18.20 | $-3.26 | 0.00 |
| 2022-09-30 | 22.75 | $-2.48 | 0.00 |
| 2022-06-30 | 13.81 | $-2.25 | 0.00 |
| 2022-03-31 | 22.73 | $-0.35 | 0.00 |
| 2021-12-31 | 37.27 | $-0.21 | 0.00 |
| 2021-09-30 | 42.32 | $0.10 | 423.20 |
| 2021-06-30 | 44.51 | $0.06 | 741.83 |
| 2021-03-31 | 36.00 | $-0.83 | 0.00 |
| 2020-12-31 | 39.89 | $-0.81 | 0.00 |
| 2020-09-30 | 28.94 | $-0.73 | 0.00 |
| 2020-06-30 | 16.35 | $-0.32 | 0.00 |
| 2020-03-31 | 9.50 | $0.41 | 23.17 |
| 2019-12-31 | 16.18 | $0.44 | 36.77 |
| 2019-09-30 | 16.63 | $0.46 | 36.14 |
| 2019-06-30 | 16.95 | $0.14 | 121.07 |
| 2019-03-31 | 17.89 | $0.16 | 111.81 |
| 2018-12-31 | 12.03 | $0.13 | 92.54 |
| 2018-09-30 | 17.50 | $0.04 | 437.50 |
| 2018-06-30 | 11.41 | $-0.04 | 0.00 |
| 2018-03-31 | 5.13 | $-0.15 | 0.00 |
| 2017-12-31 | 6.00 | $-0.21 | 0.00 |
| 2017-09-30 | 5.71 | $-0.42 | 0.00 |
| 2017-06-30 | 2.39 | $-0.47 | 0.00 |
| 2017-03-31 | 2.09 | $-0.52 | 0.00 |
| 2016-12-31 | 1.61 | $-0.55 | 0.00 |
| 2016-09-30 | 1.84 | $-0.38 | 0.00 |
| 2016-06-30 | 1.60 | $-0.39 | 0.00 |
| 2016-03-31 | 1.83 | $-0.36 | 0.00 |
| 2015-12-31 | 2.17 | $-0.35 | 0.00 |
| 2015-09-30 | 2.11 | $-0.34 | 0.00 |
| 2015-06-30 | 1.95 | $-0.32 | 0.00 |
| 2015-03-31 | 1.61 | $-0.31 | 0.00 |
| 2014-12-31 | 1.64 | $-0.32 | 0.00 |
| 2014-09-30 | 2.10 | $-0.34 | 0.00 |
| 2014-06-30 | 2.28 | $-0.27 | 0.00 |
| 2014-03-31 | 3.69 | $-0.20 | 0.00 |
| 2013-12-31 | 8.40 | $-0.10 | 0.00 |
| 2013-09-30 | 11.13 | $-0.14 | 0.00 |
| 2013-06-30 | 5.04 | $-0.28 | 0.00 |
| 2013-03-31 | 4.06 | $-0.42 | 0.00 |
| 2012-12-31 | 4.76 | $-0.42 | 0.00 |
| 2012-09-30 | 1.82 | $-0.42 | 0.00 |
| 2012-06-30 | 1.26 | $-0.42 | 0.00 |
| 2012-03-31 | 1.40 | $-0.42 | 0.00 |
| 2011-12-31 | 0.70 | $-0.56 | 0.00 |
| 2011-09-30 | 1.12 | $-0.56 | 0.00 |
| 2011-06-30 | 1.12 | $-0.56 | 0.00 |
| 2011-03-31 | 1.12 | $-0.56 | 0.00 |
| 2010-12-31 | 0.77 | $-0.56 | 0.00 |
| 2010-09-30 | 1.19 | $-0.56 | 0.00 |
| 2010-06-30 | 1.33 | $-0.56 | 0.00 |
| 2010-03-31 | 1.41 | $-0.56 | 0.00 |
| 2009-12-31 | 1.54 | $-0.56 | 0.00 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $1.218B | $0.082B |
| BioLife Solutions has pioneered the next generation of preservation solutions designed to maintain the viability and health of cellular matter and tissues during freezing, transportation and storage. Based on their proprietary bio-packaging technology and a patented understanding of the mechanism of cellular damage and death, these products enable the biotechnology and medical community to address a growing problem that exists today. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $228.801B | 26.83 |
| Boston Scientific (BSX) | United States | $156.873B | 37.41 |
| Stryker (SYK) | United States | $150.304B | 30.59 |
| EssilorLuxottica (ESLOY) | France | $143.779B | 0.00 |
| Medtronic (MDT) | Ireland | $118.071B | 16.65 |
| Lonza Group Ag (LZAGY) | Switzerland | $49.982B | 0.00 |
| Haleon (HLN) | United Kingdom | $43.547B | 24.90 |
| ResMed (RMD) | United States | $41.283B | 29.52 |
| GE HealthCare Technologies (GEHC) | United States | $33.904B | 15.94 |
| Agilent Technologies (A) | United States | $33.716B | 21.78 |
| Terumo (TRUMY) | Japan | $26.887B | 31.86 |
| Koninklijke Philips (PHG) | Netherlands | $26.663B | 17.64 |
| Insulet (PODD) | United States | $23.536B | 78.86 |
| Zimmer Biomet Holdings (ZBH) | United States | $21.155B | 13.47 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $16.315B | 0.00 |
| Baxter (BAX) | United States | $12.599B | 9.73 |
| Sunny Optical Technology (SNPTF) | China | $10.800B | 0.00 |
| Demant (WILYY) | Denmark | $8.121B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $7.925B | 29.11 |
| Lantheus Holdings (LNTH) | United States | $3.865B | 10.45 |
| Envista Holdings (NVST) | United States | $3.530B | 24.70 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| Prestige Consumer Healthcare (PBH) | United States | $3.295B | 14.62 |
| Perrigo (PRGO) | Ireland | $3.287B | 8.21 |
| ICU Medical (ICUI) | United States | $3.126B | 21.28 |
| Haemonetics (HAE) | United States | $2.651B | 11.83 |
| LeMaitre Vascular (LMAT) | United States | $2.166B | 46.45 |
| Curaleaf Holdings (CURLF) | Canada | $2.148B | 0.00 |
| Acuren (TIC) | United States | $2.126B | 0.00 |
| QuidelOrtho (QDEL) | United States | $1.886B | 11.87 |
| Green Thumb Industries (GTBIF) | United States | $1.876B | 80.57 |
| AtriCure (ATRC) | United States | $1.854B | 0.00 |
| Tilray Brands (TLRY) | Canada | $1.508B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $1.305B | 15.41 |
| Neogen (NEOG) | United States | $1.247B | 19.79 |
| AdaptHealth (AHCO) | United States | $1.246B | 17.71 |
| InMode (INMD) | Israel | $0.960B | 8.88 |
| Kestra Medical Technologies (KMTS) | United States | $0.924B | 0.00 |
| Valneva SE (VALN) | France | $0.745B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.699B | 0.00 |
| SNDL (SNDL) | Canada | $0.665B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.611B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.595B | 0.00 |
| ZimVie (ZIMV) | United States | $0.535B | 20.62 |
| Evolus (EOLS) | United States | $0.490B | 0.00 |
| Surmodics (SRDX) | United States | $0.488B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.475B | 16.36 |
| CeriBell (CBLL) | United States | $0.425B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.380B | 0.00 |
| Owens & Minor (OMI) | United States | $0.378B | 3.35 |
| Canopy Growth (CGC) | Canada | $0.362B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.340B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.317B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.302B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.301B | 0.00 |
| High Tide (HITI) | Canada | $0.292B | 0.00 |
| Omeros (OMER) | United States | $0.289B | 0.00 |
| Brainsway (BWAY) | Israel | $0.288B | 58.69 |
| Capricor Therapeutics (CAPR) | United States | $0.286B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.278B | 21.12 |
| TriSalus Life Sciences (TLSI) | United States | $0.254B | 0.00 |
| Cerus (CERS) | United States | $0.251B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.244B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.238B | 0.00 |
| Organigram Global (OGI) | Canada | $0.224B | 0.00 |
| Quanterix (QTRX) | United States | $0.214B | 0.00 |
| Exagen (XGN) | United States | $0.210B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.196B | 16.34 |
| FitLife Brands (FTLF) | United States | $0.176B | 21.66 |
| Biote (BTMD) | United States | $0.166B | 5.51 |
| Jushi Holdings (JUSHF) | United States | $0.147B | 0.00 |
| Jin Medical (ZJYL) | China | $0.128B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.115B | 0.00 |
| MacroGenics (MGNX) | United States | $0.109B | 0.00 |
| Fonar (FONR) | United States | $0.098B | 12.66 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.091B | 0.00 |
| Apyx Medical (APYX) | United States | $0.075B | 0.00 |
| Agape ATP (ATPC) | $0.069B | 0.00 | |
| Safety Shot (SHOT) | United States | $0.060B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.058B | 0.00 |
| ImmuCell (ICCC) | United States | $0.055B | 32.10 |
| Zynex (ZYXI) | United States | $0.051B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.051B | 0.00 |
| Veru (VERU) | United States | $0.048B | 0.00 |
| Nephros (NEPH) | United States | $0.043B | 33.75 |
| Modular Medical (MODD) | United States | $0.041B | 0.00 |
| United-Guardian (UG) | United States | $0.037B | 14.45 |
| Senestech (SNES) | United States | $0.023B | 0.00 |
| INLIF (INLF) | $0.017B | 0.00 | |
| Allurion Technologies (ALUR) | United States | $0.016B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.015B | 0.00 |
| Sharps Technology (STSS) | United States | $0.015B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.013B | 0.00 |
| Flora Growth (FLGC) | United States | $0.013B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.012B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.006B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.004B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| InterCure (INCR) | Israel | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.000B | 0.00 |